Cognitive function in patients prior to undergoing allogeneic hematopoietic stem cell transplantation.
Zev M NakamuraAllison M DealDonald L RosensteinLaura J QuillenStephanie A ChienWilliam A WoodThomas C SheaEliza M ParkPublished in: Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer (2020)
Cognitive impairment is common in patients scheduled to receive HSCT. Pre-transplantation evaluation of medical comorbidities and history of substance abuse may be important in identifying patients at risk for cognitive impairment. Further research characterizing the trajectory and impact of cognitive impairment on patient symptom burden and function may help improve outcomes.
Keyphrases
- cognitive impairment
- end stage renal disease
- allogeneic hematopoietic stem cell transplantation
- ejection fraction
- newly diagnosed
- chronic kidney disease
- peritoneal dialysis
- acute myeloid leukemia
- type diabetes
- prognostic factors
- stem cells
- acute lymphoblastic leukemia
- metabolic syndrome
- adipose tissue
- cell therapy
- weight loss